Osaka Biotech ＆ Pharma Networking Events - Webinar schedule
At this daily webinar hosted by each collaborating organization, we welcome speakers from trade agencies, cutting-edge companies and advanced research institutions!
*Returnt to the event outline Japanese / English
note:
[Updated regularly]
| date | Region | Contents |
| Wednesday Nov. 22 |
Osaka | • International collaboration with Biocommunity Kansai (BiocK) |
| Friday Nov. 24 |
Queensland | |
| Monday Nov. 27 |
Switzerland | |
| Tuesday Nov. 28 |
Québec | |
| Wednesday Nov. 29 |
Australia Victoria | |
| Thursday Nov. 30 |
New Zealand |
• The New Zealand – Japan Relationship • The BioTech Economy in New Zealand • Pitch Presentation |
| Friday Dec. 1 |
Canada British Columbia |
• British Columbia Provincial Government’s Support and New Strategy (TBC) • BC Market Overview and Highlights (TBC) • BC’s Innovation and Business Partnerships with Global Companies (TBC) • Pitching session by BC Companies |
| Monday Dec. 4 |
London | |
| Tuesday Dec. 5 |
Wales |
• Improving the Health and Wellbeing of the Citizen: Advanced Physical and Digital Engineering in Indoor Air and Environmental Quality in Build Environments • The TriTech Institute – providing solutions for research, innovation, and Value-Based Healthcare evaluation. • Reacta Healthcare – Integrating Medicine With Food Science • The Assistive Technologies Innovation Centre (ATiC)-Design research for the Life Sciences, Health and Wellbeing. • Why Wales for Medtech Health |
Wednesday, November 22 Osaka day
11:00am – 11:20pmInternational collaboration with Biocommunity Kansai (BiocK)
|
Biocommunity Kansai (BiocK) is the Japanese Global Biocommunity. Our goal is the creating an ultimate ecosystem for the bio-fields in Kansai,collaborations to solve many social problems in the world and developing the bioindustry together. We introduce 3 main action plans. 1. Facilitating innovation 2. Creating networks 3. Disseminating information We propose international collaboration with all of the world. |
Video on demand: Yes
note:
Friday, November 24 Queensland day
00:00am – 00:00pmPRESNTATIONTITLE
| OUTLINE |
Video on demand:
note:
Monday, November 27 Switzerland day
00:00am – 00:00pmPRESNTATIONTITLE
| OUTLINE |
Video on demand:
note:
Tuesday, November 28 Québec day
00:00am – 00:00pmPRESNTATIONTITLE
| OUTLINE |
Video on demand:
note:
Wednesday, November 29 Australia Victoria day
00:00am – 00:00pmPRESNTATIONTITLE
| OUTLINE |
Video on demand:
note:
Thursday, November 30 New Zealand day
10:00am – 10:05amThe New Zealand – Japan Relationship
| https://www.nzte.govt.nz/ |
Video on demand: Yes
note:
10:10am – 10:15amThe BioTech Economy in New Zealand
| https://biotechnz.org.nz/ |
Video on demand: Yes
note:
10:30am – 12:10amPitch Presentation
|
• Novel therapies for patients with vision disorders by Carissa Fonseca / CEO at TheiaNova (https://www.theianova.com/) • A novel cell therapy for Huntington’s Disease by Kimberlee Jordan & Bronwen Connor / Professor at Auckland UniServices (https://profiles.auckland.ac.nz/b-connor) • The future of orthopeadic planning by Ju Zhang / CEO at Formus Labs (https://www.formuslabs.com/) • Advancing ADCs – Novel payloads by Aran Sisley & Moana Tercel / Senior Research Fellow at Auckland UniServices (https://www.fmhs.auckland.ac.nz/en/sms/about/our-departments/auckland-cancer-society-research-centre.html) • Advancing ADCs – Novel linkers by Thomas Grant & Iman Kavianinia / Senior Research Fellow at Auckland UniServices (https://profiles.auckland.ac.nz/i-kavianinia) • Molecular evolution: early life, early genomes and of the eukaryote cell by Anthony Poole / Professor of Biological Sciences at University of Auckland (https://profiles.auckland.ac.nz/a-poole) • Genomics – Determinants of a Healthy Life by Justin O’Sullivan / Professor and Director of Liggins Institute at University of Auckland (https://www.auckland.ac.nz/en/liggins.html) |
Video on demand: Yes
note:
Friday, December 1 Canada British Columbia day
09:30am – 09:50amBritish Columbia Provincial Government’s Support and New Strategy (TBC)
| coming soon |
Video on demand: Yes
note:
09:50am – 10:05amBC Market Overview and Highlights (TBC)
| coming soon |
Video on demand: Yes
note:
10:05am – 10:15amBC’s Innovation and Business Partnerships with Global Companies (TBC)
| coming soon |
Video on demand: Yes
note:
10:15am – 10:55amPRESNTATIONTITLE
| This pre-recorded session will provide 5 min pitching presentations by BC companies. |
Video on demand: Yes
note:
Monday, December 4 London day
00:00am – 00:00pmPRESNTATIONTITLE
| OUTLINE |
Video on demand:
note:
Tuesday, December 5 Wales day
10:00am – 10:15amImproving the Health and Wellbeing of the Citizen: Advanced Physical and Digital Engineering in Indoor Air and Environmental Quality in Build Environments
| Introduction of Respiratory Innovation Wales and opportunities for R&D |
Video on demand: Yes
note:
10:15am – 10:30amThe TriTech Institute – providing solutions for research, innovation, and Value-Based Healthcare evaluation.
|
The current NHS set-up and clinical evaluation systems are not keeping up with technical advances, UK/EU legal requirements and patient demand. TriTech’s multi-disciplinary team develop, test and re-test innovations from within the NHS. We give immediate clinical and scientific opinions on feasibility and safety, consider what is needed to prove efficacy (patient outcomes) and value. We support companies to grow whilst improving patient care through:
•A single point of access to the NHS for med-tech designers and manufacturers |
Video on demand: Yes
note:
10:30am – 10:35amReacta Healthcare – Integrating Medicine With Food Science
|
Reacta Healthcare develop and manufacture challenge meals for use in food allergy clinical trials. Building from this foundation we offer innovative development and manufacturing solutions across the food allergy space. Reacta Healthcare, established in 2013, operates from a pharmaceutical manufacturing facility in Deeside, North Wales. It is licenced to manufacture challenge meals for use in clinical trials. These challenge meals are currently used to diagnose and monitor food allergy in numerous worldwide therapeutic trials. Patents for the challenge meals have been granted in a number of countries. Reacta Healthcare is developing its in-house analytical capability and has plans in place for expansion into niche areas of food allergen development and manufacture. This will include all aspects from sourcing through to manufacture of end product. We are looking to work with partners across this developing clinical space. |
Video on demand: Yes
note:
10:35am – 10:50amThe Assistive Technologies Innovation Centre (ATiC)-Design research for the Life Sciences, Health and Wellbeing.
| ATiC is a user centred design research and innovation laboratory which collaborates with partners across the life sciences, health, and social care sectors to co-create and evaluate new health technologies. Our research focus is on understanding people’s needs and performance during their interaction with physical and digital healthcare products, services, systems, and spaces. These insights help our partners develop innovative new solutions for health and wellbeing, which transform lives. Powered by a diverse multidisciplinary team of artists, designers, architects, scientists, and engineers, ATiC uses a multi-modal approach incorporating user-centred thinking, design research methods, and objective physical measurement tools. ATiC provides research and innovation capabilities in User Experience, Usability Engineering and Human Computer Interaction; Behavioural, Cognitive and Affective Observation and Measurement; Physical Performance and Biomechanical Data Capture and Analysis; Computer Simulation, Modelling & Optimisation for User Testing using Virtual and Augmented Reality Simulation, 3D Scanning, CAD, 3D Printing and Prototyping. |
Video on demand: Yes
note:
10:50am – 11:05amWhy Wales for Medtech Health
| Wales offers specific commercial opportunities for your company to develop and commercialise new or disruptive technologies. Our devolved National Health Service is committed to supporting innovative technologies and therapies to reduce costs and improve patient outcomes. Wales also has competitive strengths in the enabling technologies that underpin digital innovation in healthcare, namely Cyber security, big data analytics, and the world’s first compound semiconductor cluster. In Wales you can engage with a vibrant research culture involving the NHS, industry, academic institutions and government developing innovative e-health solutions. Our researchers lead the world in areas including wound healing, stem cells, neurosciences, e-health, in vitro diagnostics and medical devices. We make it easy for industry to collaborate with NHS clinicians and universities to move research projects towards market readiness. |
Video on demand: Yes
note:
